Patents
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
04/2009
04/01/2009CN101397288A Method for preparing 2,2-dialkyl-5-hydroxymethyl-1,3-dioxanes compounds
03/2009
03/31/2009US7511144 Reverse hydroxamic acid derivatives
03/31/2009CA2356121C Novel propargylether derivatives
03/26/2009US20090082395 Soluble epoxide hydrolase inhibitors
03/24/2009US7507840 Nonlinear optically active compounds that include a pi-donor conjugated to a pi-acceptor through a pi-electron conjugated bridge
03/24/2009US7507764 Amphiphilic [5:1]- and [3:3]- hexakisadducts of fullerenes
03/24/2009US7507732 6,7-Dihydro-5H-cyclopenta[b]pyridine and 5,6,7,8-tetrahydroquinoline compounds; 5-HT2c receptor agonists; to treat diseases like obesity, depression, atypical depression, anxiety, epilepsy, lower urinary tract dysfunction; less toxic; selectivity
03/19/2009WO2009035951A2 Soluble epoxide hydrolase inhibitors
03/19/2009WO2008139467A3 Lipid conjugated cyclic carbonate derivatives, their synthesis, and uses
03/19/2009US20090076062 Organic Compounds
03/18/2009EP2036547A2 Treatment for Attention-Deficit Hyperactivity Disorder
03/18/2009EP1689380A4 Method for treating adamts-5-associated disease
03/18/2009CN101389619A Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
03/18/2009CN101386580A Aminopropancdiols derivates, preparation method thereof and medicament composition and use thereof
03/18/2009CN100469761C Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
03/17/2009US7504524 comprising the oxidation of the ketone function of a cyclic compound
03/17/2009US7504395 Treatment for attention-deficit hyperactivity disorder
03/12/2009WO2009031437A1 Tetra- or penta-cyclic liquid crystalline compound having lateral fluorine, liquid crystal composition, and liquid crystal display element
03/12/2009WO2009030396A1 Method for the production of lactic acid dilactide or polyesters producible thereof
03/12/2009WO2009030330A1 Condensation and washing device, polymerisation device and method for cleaning process steam during the production of polylactide
03/12/2009WO2008145941A3 Coproduction of cyclic carbonates and of nitriles and/or of fatty amines
03/12/2009US20090069579 Process and compound
03/12/2009US20090066905 Componds for use in liquid crystal devices
03/12/2009US20090065739 Liquid crystal compound having chloronaphthalene moiety, liquid crystal composition, and optical device
03/11/2009EP1835902B1 Spiro[bornyl-2,4'-(1,3-dioxanes)] and their uses as fragrance ingredients
03/11/2009CN101381361A Organic compound for recording layer and optical recording medium including the same
03/11/2009CN100467459C 1,4-benzodioxane sulfonic acid compound and use thereof as electron-acceptor material
03/11/2009CN100467441C Aminomethyl-phenyl-cyclohexanone derivatives
03/11/2009CN100467436C Process for preparing alkoxy- and aryloxy-phenols
03/05/2009WO2008088487A3 Phosphorus-sulfur fr additives and polymer systems containing same
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives
03/05/2009US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same
03/05/2009DE102007041854A1 Bifunktionelle DHA-Derivate Bifunctional DHA derivatives
03/04/2009EP2031083A1 Method for manufacturing lactic acid dilactid or polyesters from lactic acid
03/04/2009EP2030667A1 Condensation and washing device, polymerisation device and cleaning of process vapour in polylactide production
03/03/2009US7498460 Isophthalic acid derivatives
03/03/2009US7498394 (2-Methyl)-acrylic acid 2-benzyloxycarbonyloxy-ethyl ester; higherpolymerization rates and that polymerize more completely than conventional monomers with multiple vinyl functionalities; curing efficiency, allows optimum polymer properties to be achieved with minimized irradiation times and intensities
03/03/2009US7498292 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
02/2009
02/26/2009WO2009024492A1 Leukotriene b4 inhibitors
02/26/2009CA2696967A1 Leukotriene b4 inhibitors
02/25/2009EP2027087A2 Intracellular kinase inhibitors
02/25/2009CN101372483A Method for synthesizing substituted benzo (1,4) dioxane derivative
02/19/2009WO2009022311A2 1,2-diamido-ethylene derivatives as orexin antagonists
02/19/2009CA2694993A1 1,2-diamido-ethylene derivatives
02/18/2009CN101367789A Method for preparing 1,4-diethyleno dioxide ketone
02/17/2009CA2320756C Process for the production of optically enriched (r)- or (s)-albuterol
02/12/2009WO2009019561A2 Process for preparing chiral compounds
02/12/2009US20090043115 Process for Producing Simvastatin
02/12/2009US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
02/12/2009US20090042973 Inhibitors of aspartyl protease
02/12/2009CA2695357A1 Process for preparing chiral compounds
02/05/2009WO2009017261A1 Method for manufacturing ultrafine p dioxanone
02/05/2009WO2008150486A3 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
02/05/2009US20090036691 Analogs of dicodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
02/04/2009CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
01/2009
01/29/2009WO2008145941A9 Coproduction of cyclic carbonates and of nitriles and/or of fatty amines
01/29/2009US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor
01/29/2009US20090029903 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors
01/28/2009EP2018361A1 Halogenated cyclic lactones and polymers made therefrom
01/27/2009US7482044 dielectrically positive liquid crystalline media comprising a dielectrically positive component, component A, comprising a dielectrically positive compound of formula I, and optionally a second dielectrically positive component, component B, comprising one or more dielectrically positive compounds
01/22/2009WO2009010527A1 Process for preparing cyclic glycerol acetals or cyclic glycerol ketals or mixtures thereof
01/21/2009CN100453539C 5-methylene-1,3,-dioxolane-4-one inducer, doubling body, chemical amplification type anti-corrosion composition and forming method
01/20/2009CA2220759C 1,4-benzodioxin derivatives
01/15/2009WO2008125342A3 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
01/15/2009US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use
01/15/2009US20090018116 Therapeutic Compounds
01/14/2009CN100451014C Process for making chiral 1,4-disubstituted piperazines
01/13/2009US7476690 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
01/13/2009US7476673 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology
01/08/2009WO2009004990A1 Fp receptor agonist
01/08/2009US20090012319 Process for the preparation 2-substituted-derivatives of estrone and estradiol
01/08/2009US20090012069 Novel Antidiabetic Compounds
01/08/2009US20090009061 Composition for Conductive Materials Comprising Crosslinkable Arylamine Compounds and Use Thereof in Electronic Devices and Electronic Equipment
01/07/2009EP1431285B1 Reverse hydroxamic acid derivatives
01/07/2009CN100448880C 2'oxo-voruscharin and derivatives thereof
12/2008
12/31/2008CN100447088C Rare earth or gallium additive composition, methods for preparing same and use thereof as catalyst
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470798 7,8-bicycloalkyl-chroman derivatives
12/30/2008US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions
12/25/2008US20080318958 New utilities of tricyclic compounds
12/25/2008US20080318779 Fungicidal Composition Containing Acid Amide Derivative
12/24/2008WO2008155818A1 Preventive or therapeutic agent for frequent urination and urinary incontinence
12/24/2008CN101331114A 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
12/24/2008CN101330831A Bactericidal composition comprising carboxylic acid amide derivative
12/23/2008US7468462 Modulate activity of Nuclear Retinoid receptors; regulating cell differentiation and cell cycle processes and cellular signaling processes regulated by thyroid hormone, vitamin D, all-trans retinoic acid; 2-[6-(3-Adamantan-1-yl-4-methoxyphenyl)-naphthalen-2-yl]-3-hydroxy-cyclopent-2-enone
12/23/2008US7468393 Diarylsulfones as 5-HT2A antagonists
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080311113 Method for treating adamts-5-associated disease
12/17/2008CN101326154A Intermediate compounds for the preparation of statins
12/17/2008CN100443480C Tricyclic compound and its preparation and use
12/16/2008US7465733 trans-1-{2-[(3,5-dibromobenzyl)oxy]-2,3-dihydro-1H-inden-1-yl}piperazine; serotonin reuptake inhibitor and/or neurokinin NK1 antagonist; antidepressant, anxiolytic agent; cognition activator; psychological disorders; obesity, gastrointestinal disorders
12/16/2008US7465415 Reaction product of a ring-opening cyclic ester or carbonate and a photochromic initiator, especially a naphtho[1,2-b]quinone with one or more hydroxy groups, e.g., (1) 3,3-di(4-methoxyphenyl)-6,7-dimethoxy-13-methyl-13-(2-(2-hydroxyethoxy)ethoxy)-3H,13H-indeno[2,1-f]naphtho[1,2-b]pyran.
12/11/2008WO2008150486A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/11/2008WO2008148853A1 N-phenyl hydrazides as modulators of the ghrelin receptor
12/11/2008US20080306231 Novel perfluoroalkyl vinyl ether compound, process for preparing copolymer by using the compound, and optical plastic materials comprising copolymer prepared by the process
12/11/2008US20080306013 Illudin analogs useful as antitumor agents
12/10/2008CN101321789A Process for producing trioxane and at least one comonomer
12/10/2008CN100441575C Process for preparation of cyclid esters and method for purification of the same
12/10/2008CN100441574C Tricyclic compounds, their production and use
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 103